Long-term partner Acton Capital (for whom I act as a venture partner for North-America) has…
Portfolio
Unbounce makes building, publishing and A/B testing of landing pages super-easy. It does not require any IT involvement and puts the marketer into the driver seat. This makes the product so successful and is the basic SaaS value proposition: let the user be the buyer and offer him a risk-free monthly subscription plan. I have […]
Long-term partner Acton Capital (for whom I act as a venture partner for North-America) has…
I have been watching Michael Cole and his Vancouver-based company Fitbrains for almost two years…
Unbounce makes building, publishing and A/B testing of landing pages super-easy. It does not require any IT involvement and puts the marketer into the driver seat. This makes the product so successful and is the basic SaaS value proposition: let the user be the buyer and offer him a risk-free monthly subscription plan.
I have watched the team over the years bootstrapping their business – heads-down building product, listening to customers and building a great reputation in the marketplace. Now they felt it was the right time to raise money to scale the business even faster and they assembled a top notch group of investors led by Mark MacLeod from Real Ventures.
I really hope that many other start-ups look at Unbounce as a role model for their focus on solving a real problem, understanding customer needs and building a great product. Congrats, Unbounce team, well done – excited to be aboard!
P.S.: Funding announcement happened 2 weeks ago but only got around to blogging about it now.
Health / Biology, Portfolio, Version One
Shifting healthcare systems from reactive to proactive care is critical – the best outcomes occur when people can take action early, before a condition becomes a diagnosis. That’s why we are excited to announce that we have led a $2.5m pre-seed round for NiaHealth and are thrilled that they are coming out of stealth and […]
We are continually refining our thesis on healthcare, from looking at clinical-grade at-home diagnostics to biotech and…
Over the past year, some of the most interesting and intellectually-stimulating pitches we heard have…